3[1]Charney D S, et al. Serotonin function in anxiety Ⅱ. Effects of the serotonin agonist mCPP in panic disorder patients and healthy subjects. Psychopharmacology, 1987, 92: 14-24.
4[2]Fiorella, et al. The role of the 5 - HT2A and 5 - HT2c receptors in the stimulus effects of m-chlorophenylpiperazine. Psychopharmacology, 1995, 119:222-230.
5[3]Conn P J, Sanders-Bush E. Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic 5-HT1c and 5-HT2receptors. J Pharmacol Exp Ther, 1987, 242: 552-557.
6[4]Kennett G A, et al. Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1c antagonists. Eur J Pharmaco, 1989, 164:445-454.
7[5]Gribel G, et al. m-Chlorophenylpiperazine enhances neophobic and anxious behaviour in mice. Neuroreport, 1991, 2:627-629.
8[6]Gibson E L, et al. Evidence that mCPP-induced anxiety in the plus maze is mediated by postnaptic 5-HT2c receptors but not by sympathomimetic effects Neuropharmacology, 1994, 33:457-465.
9[7]Bilkei-Gorzo A, et al. mCPP-induced anxiety in the light-dark box in rats-a new method for screening anxiolytic activity. Psychopharmacology, 1998, 136:291-298.
10[8]Cao B J, Rodgers R J. Comparative effects of novel 5-HT1A receptor ligands LY293284 (full agonist), LY315712 (partial agonist),and LY 297996, on Plus-maze anxiety in mice. Psychopharmacology, 1998, 139:183-195.
